Cryo-Save Group N.V.: Operating profit up 80% and number of combined cord samples stored up 267%
(Thomson Reuters ONE) -
Click here for the press release
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), Europe's
leading adult stem cell storage bank, announces its trading update for the
quarter ended 30 September 2010.
Highlights for the period were:
* Third quarter revenue of ?9.6 million (Q3 2009: ?9.7 million). For the
period to 30 September 2010, revenue was up 3% to ?29.1 million (30
September 2009: ?28.4 million)
* EBITA(*) up 47% to ?1.1 million (Q3 2009: ?0.7 million). For the period to
30 September 2010, EBITA was up 29% to ?3.6 million (30 September 2009: ?2.7
million)
* Operating profit up 80% to ?0.7 million (Q3 2009: ?0.4 million). For the
period to 30 September 2010, operating profit was up 42% to ?2.6 million (30
September 2009: ?1.8 million)
* Number of new cord tissue samples stored up 267% to 3,200 (Q3 2009: 900
samples). Over 60% of new customers opted for the combined service of cord
blood and cord tissue storage, where it is available
* Volume growth of 6,200 samples (Q3 2009: 7,300). At 30 September 2010, the
total number of samples stored was over 141,000
* Further roll out of new product Cryo-Lip(®), which allows collection,
processing and storage of adult stem cells from fatty tissue. Doctors in
Italy, Spain, Greece, Cyprus, Bulgaria and Hungary have been trained and
certified to offer this service, and the first samples of Cryo-Lip(® )have
now been processed and stored in the Group's facility in Belgium
(*)EBITA is defined as Earnings Before Interest, Taxation and Amortisation of
identified intangible assets.
Highlights after 30 September 2010 were:
* Cryo-Save celebrated the first anniversary of its NYSE Euronext Amsterdam
listing on 1 November 2010 by participating in the market opening ceremony
* On 3 November 2010, Cryo-Save announced the acquisition of its Bulgarian
distributor, Tissue Bank Cryo Center Bulgaria AD, the leading company for
stem cell banking in Bulgaria, strengthening the Group's leading position in
Eastern Europe, one of its fastest growing markets
Arnoud van Tulder, Chief Executive officer, commented:
"These strong results are very pleasing and demonstrate the resilience of our
business model under the challenging economic circumstances, especially within
our key markets in southern Europe.
Focus on customers, costs and cash remains a key discipline for us, and we saw a
modest improvement in the European economy in September and October, which gives
us confidence for the near future."
Enquiries:
Cryo-Save Group + 31 (0) 575 548 998
Arnoud van Tulder, Chief Executive Officer
SPJ Financiële Communicatie (The Netherlands) +31 (0)20 6478181
Kees Jongsma/Leon Melens
Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550
Chris Theis
College Hill (UK) + 44 (0) 20 7457 2020
Rozi Morris/ Adrian Duffield
Free footage is available on www.videobankonline.com.
About Cryo-Save
With more than 141,000 samples saved, Cryo-Save is the leading stem cell bank in
Europe and one of the fastest growing in the world. Driven by its international
business strategy, Cryo-Save is now represented in 40 countries on three
continents with state-of-the-art processing facilities in Belgium, Germany,
Dubai, India and France.
[HUG#1461253]
click here for the press release:
http://hugin.info/143308/R/1461253/400446.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 11.11.2010 - 07:00 Uhr
Sprache: Deutsch
News-ID 48643
Anzahl Zeichen: 4602
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 311 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cryo-Save Group N.V.: Operating profit up 80% and number of combined cord samples stored up 267%"
steht unter der journalistisch-redaktionellen Verantwortung von
Cryo-Save Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
